Vanguard Group
CORT icon

Vanguard Group’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$711M Sell
9,680,592
-301,376
-3% -$22.1M 0.01% 833
2025
Q1
$1.14B Sell
9,981,968
-133,656
-1% -$15.3M 0.02% 605
2024
Q4
$510M Buy
10,115,624
+109,294
+1% +$5.51M 0.01% 1026
2024
Q3
$463M Buy
10,006,330
+452,624
+5% +$20.9M 0.01% 1091
2024
Q2
$310M Sell
9,553,706
-12,076
-0.1% -$392K 0.01% 1243
2024
Q1
$241M Buy
9,565,782
+28,250
+0.3% +$712K ﹤0.01% 1400
2023
Q4
$310M Buy
9,537,532
+239,887
+3% +$7.79M 0.01% 1268
2023
Q3
$253M Sell
9,297,645
-13,580
-0.1% -$370K 0.01% 1315
2023
Q2
$207M Sell
9,311,225
-1,123,519
-11% -$25M ﹤0.01% 1459
2023
Q1
$226M Buy
10,434,744
+89,714
+0.9% +$1.94M 0.01% 1389
2022
Q4
$210M Buy
10,345,030
+12,953
+0.1% +$263K 0.01% 1401
2022
Q3
$265M Buy
10,332,077
+458,414
+5% +$11.8M 0.01% 1212
2022
Q2
$235M Sell
9,873,663
-565,089
-5% -$13.4M 0.01% 1329
2022
Q1
$235M Sell
10,438,752
-358,725
-3% -$8.08M 0.01% 1449
2021
Q4
$214M Sell
10,797,477
-1,073,041
-9% -$21.2M ﹤0.01% 1563
2021
Q3
$234M Sell
11,870,518
-106,866
-0.9% -$2.1M 0.01% 1510
2021
Q2
$264M Sell
11,977,384
-410,343
-3% -$9.03M 0.01% 1460
2021
Q1
$295M Buy
12,387,727
+391,578
+3% +$9.32M 0.01% 1323
2020
Q4
$314M Buy
11,996,149
+264,345
+2% +$6.92M 0.01% 1164
2020
Q3
$204M Buy
11,731,804
+492,458
+4% +$8.57M 0.01% 1271
2020
Q2
$189M Buy
11,239,346
+121,519
+1% +$2.04M 0.01% 1304
2020
Q1
$132M Buy
11,117,827
+169,081
+2% +$2.01M 0.01% 1371
2019
Q4
$132M Buy
10,948,746
+42,085
+0.4% +$509K ﹤0.01% 1617
2019
Q3
$154M Sell
10,906,661
-41,458
-0.4% -$586K 0.01% 1493
2019
Q2
$122M Buy
10,948,119
+12,558
+0.1% +$140K ﹤0.01% 1640
2019
Q1
$128M Buy
10,935,561
+161,567
+1% +$1.9M 0.01% 1617
2018
Q4
$144M Buy
10,773,994
+411,434
+4% +$5.5M 0.01% 1455
2018
Q3
$145M Buy
10,362,560
+37,781
+0.4% +$530K 0.01% 1602
2018
Q2
$162M Buy
10,324,779
+1,573,511
+18% +$24.7M 0.01% 1490
2018
Q1
$144M Sell
8,751,268
-618,911
-7% -$10.2M 0.01% 1507
2017
Q4
$169M Buy
9,370,179
+3,134,600
+50% +$56.6M 0.01% 1410
2017
Q3
$120M Buy
6,235,579
+1,795,515
+40% +$34.7M 0.01% 1603
2017
Q2
$52.4M Buy
4,440,064
+689,554
+18% +$8.14M ﹤0.01% 1997
2017
Q1
$41.1M Buy
3,750,510
+359,177
+11% +$3.94M ﹤0.01% 2102
2016
Q4
$24.6M Buy
3,391,333
+307,569
+10% +$2.23M ﹤0.01% 2328
2016
Q3
$20M Buy
3,083,764
+104,029
+3% +$676K ﹤0.01% 2356
2016
Q2
$16.3M Buy
2,979,735
+193,729
+7% +$1.06M ﹤0.01% 2417
2016
Q1
$13M Buy
2,786,006
+25,697
+0.9% +$120K ﹤0.01% 2475
2015
Q4
$13.7M Buy
2,760,309
+57,086
+2% +$284K ﹤0.01% 2464
2015
Q3
$10.2M Buy
2,703,223
+75,636
+3% +$284K ﹤0.01% 2599
2015
Q2
$15.8M Buy
2,627,587
+378,204
+17% +$2.27M ﹤0.01% 2455
2015
Q1
$12.6M Buy
2,249,383
+47,087
+2% +$264K ﹤0.01% 2534
2014
Q4
$6.61M Buy
2,202,296
+45,413
+2% +$136K ﹤0.01% 2747
2014
Q3
$5.78M Buy
2,156,883
+8,639
+0.4% +$23.2K ﹤0.01% 2756
2014
Q2
$6.02M Buy
2,148,244
+18,849
+0.9% +$52.8K ﹤0.01% 2746
2014
Q1
$9.28M Buy
2,129,395
+222,944
+12% +$972K ﹤0.01% 2531
2013
Q4
$6.14M Sell
1,906,451
-94,507
-5% -$304K ﹤0.01% 2684
2013
Q3
$3.18M Buy
2,000,958
+20,184
+1% +$32.1K ﹤0.01% 2948
2013
Q2
$3.43M Buy
+1,980,774
New +$3.43M ﹤0.01% 2867